Cargando…

Elamipretide (SS-31) Ameliorates Isoflurane-Induced Long-Term Impairments of Mitochondrial Morphogenesis and Cognition in Developing Rats

Mitochondria are supposed to be involved in the early pathogenesis of general anesthesia (GA)-induced neurotoxicity and long-term cognitive deficits in developing brains. However, effective pharmacologic agents targeted on mitochondria during GA exposure are lacking. This study explores the protecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Jing, Hao, Shuangying, Sun, Xiao-Ru, Zhang, Hui, Li, Huihui, Zhao, Hongting, Ji, Mu-Huo, Yang, Jian-Jun, Li, Kuanyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403826/ https://www.ncbi.nlm.nih.gov/pubmed/28487636 http://dx.doi.org/10.3389/fncel.2017.00119

Ejemplares similares

Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice
por: Zhao, Weixing, et al.
Publicado: (2019)

Peptide SS-31 upregulates frataxin expression and improves the quality of mitochondria: implications in the treatment of Friedreich ataxia
por: Zhao, Hongting, et al.
Publicado: (2017)

A Mitochondrion-Targeted Antioxidant Ameliorates Isoflurane-Induced Cognitive Deficits in Aging Mice
por: Wu, Jing, et al.
Publicado: (2015)

The effects of a mitochondrial targeted peptide (elamipretide/SS31) on BAX recruitment and activation during apoptosis
por: Grosser, Joshua A., et al.
Publicado: (2021)

Mitochondrion-Targeted Peptide SS-31 Inhibited Oxidized Low-Density Lipoproteins-Induced Foam Cell Formation through both ROS Scavenging and Inhibition of Cholesterol Influx in RAW264.7 Cells
por: Hao, Shuangying, et al.
Publicado: (2015)

Chronic administration of mitochondrion-targeted peptide SS-31 prevents atherosclerotic development in ApoE knockout mice fed Western diet
por: Zhang, Meng, et al.
Publicado: (2017)

The mitochondrially targeted peptide elamipretide (SS-31) improves ADP sensitivity in aged mitochondria by increasing uptake through the adenine nucleotide translocator (ANT)
por: Pharaoh, Gavin, et al.
Publicado: (2023)

Elamipretide (SS-31) Improves Functional Connectivity in Hippocampus and Other Related Regions Following Prolonged Neuroinflammation Induced by Lipopolysaccharide in Aged Rats
por: Liu, Yang, et al.
Publicado: (2021)

Iron regulatory protein deficiency compromises mitochondrial function in murine embryonic fibroblasts
por: Li, Huihui, et al.
Publicado: (2018)

Elamipretide Improves Mitochondrial Function in the Failing Human Heart
por: Chatfield, Kathryn C., et al.
Publicado: (2019)

NLRP3 inflammasome-dependent pyroptosis is proposed to be involved in the mechanism of age-dependent isoflurane-induced cognitive impairment
por: Yin, Lei, et al.
Publicado: (2018)

Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy
por: Karaa, Amel, et al.
Publicado: (2018)

A randomized crossover trial of elamipretide in adults with primary mitochondrial myopathy
por: Karaa, Amel, et al.
Publicado: (2020)

Neuroprotective Effects of a Small Mitochondrially-Targeted Tetrapeptide Elamipretide in Neurodegeneration
por: Nhu, Nguyen Thanh, et al.
Publicado: (2022)

SS-31, a Mitochondria-Targeting Peptide, Ameliorates Kidney Disease
por: Zhu, Yuexin, et al.
Publicado: (2022)

Barth syndrome cardiomyopathy: targeting the mitochondria with elamipretide
por: Sabbah, Hani N.
Publicado: (2020)

Abnormalities of Mitochondrial Dynamics in the Failing Heart: Normalization Following Long-Term Therapy with Elamipretide
por: Sabbah, Hani N., et al.
Publicado: (2018)

Elamipretide Attenuates Pyroptosis and Perioperative Neurocognitive Disorders in Aged Mice
por: Zuo, Youmei, et al.
Publicado: (2020)

Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial Myopathy: The MMPOWER-3 Randomized Clinical Trial
por: Karaa, Amel, et al.
Publicado: (2023)

Mammalian mitochondrial iron–sulfur cluster biogenesis and transfer and related human diseases
por: Zhang, Wenxin, et al.
Publicado: (2021)

GLYX-13 pretreatment ameliorates long-term isoflurane exposure-induced cognitive impairment in mice
por: Liu, Huan, et al.
Publicado: (2019)

Inhibiting the NLRP3 Inflammasome With MCC950 Ameliorates Isoflurane-Induced Pyroptosis and Cognitive Impairment in Aged Mice
por: Fan, Yunxia, et al.
Publicado: (2018)

Phosphorylation of Akt by SC79 Prevents Iron Accumulation and Ameliorates Early Brain Injury in a Model of Experimental Subarachnoid Hemorrhage
por: Hao, Shuangying, et al.
Publicado: (2016)

Effects of Elamipretide on Autophagy in Renal Cells of Pigs with Metabolic Syndrome
por: Hong, Siting, et al.
Publicado: (2022)

Elamipretide effects on the skeletal muscle phosphoproteome in aged female mice
por: Campbell, Matthew D., et al.
Publicado: (2022)

SS31 Ameliorates age-related activation of NF-κB signaling in senile mice model, SAMP8
por: Hao, Zhi-Hua, et al.
Publicado: (2016)

Iron overload contributes to general anaesthesia-induced neurotoxicity and cognitive deficits
por: Wu, Jing, et al.
Publicado: (2020)

Cur@SF NPs alleviate Friedreich’s ataxia in a mouse model through synergistic iron chelation and antioxidation
por: Xu, Li, et al.
Publicado: (2022)

Effects of elamipretide on skeletal muscle in dogs with experimentally induced heart failure
por: Sabbah, Hani N., et al.
Publicado: (2019)

The mitochondrial antioxidant SS-31 increases SIRT1 levels and ameliorates inflammation, oxidative stress and leukocyte-endothelium interactions in type 2 diabetes
por: Escribano-Lopez, Irene, et al.
Publicado: (2018)

Elamipretide for Barth syndrome cardiomyopathy: gradual rebuilding of a failed power grid
por: Sabbah, Hani N.
Publicado: (2021)

Natural history comparison study to assess the efficacy of elamipretide in patients with Barth syndrome
por: Hornby, Brittany, et al.
Publicado: (2022)

Elamipretide mitigates ischemia-reperfusion injury in a swine model of hemorrhagic shock
por: Patel, N., et al.
Publicado: (2023)

Identifying responders to elamipretide in Barth syndrome: Hierarchical clustering for time series data
por: Van den Eynde, Jef, et al.
Publicado: (2023)

Elamipretide reduces pyroptosis and improves functional recovery after spinal cord injury
por: Jiang, Wu, et al.
Publicado: (2023)

SS-31 Provides Neuroprotection by Reversing Mitochondrial Dysfunction after Traumatic Brain Injury
por: Zhu, Yihao, et al.
Publicado: (2018)

Synthesis, Characterization, and Specific Localization of Mitochondrial-Targeted Antioxidant Peptide SS31 Probe
por: He, Yuan, et al.
Publicado: (2021)

Beneficial effects of SS-31 peptide on cardiac mitochondrial dysfunction in tafazzin knockdown mice
por: Russo, Silvia, et al.
Publicado: (2022)

Targeting Mitochondria by SS-31 Ameliorates the Whole Body Energy Status in Cancer- and Chemotherapy-Induced Cachexia
por: Ballarò, Riccardo, et al.
Publicado: (2021)

SS-31 Peptide Reverses the Mitochondrial Fragmentation Present in Fibroblasts From Patients With DCMA, a Mitochondrial Cardiomyopathy
por: Machiraju, Pranav, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_d0lo95gh8rajpqi6mvmobr69fs